Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:50 UTC
  • 3
  • 1 comments

Grindr nomineert drie nieuwe bestuursleden voor zijn Raad van Bestuur

Market reaction Comment Full text

GRINDR INC. (GRND)

  • Business News
  • May 01, 2026, 16:49 UTC
  • 3
  • 1 comments

Grindr stellt drei neue Kandidaten fürs Board of Directors vor

Market reaction Comment Full text

ARVINAS, INC. (ARVN)

  • Business News
  • May 01, 2026, 16:43 UTC
  • 2
  • 1 comments

Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

Market reaction Comment Full text

INFORMATION SERVICES GROUP INC. (III)

  • Business News
  • May 01, 2026, 16:39 UTC
  • 2
  • 1 comments

亚太地区企业加速推进SAP现代化转型

Market reaction Comment Full text

INFORMATION SERVICES GROUP INC. (III)

  • Business News
  • May 01, 2026, 16:36 UTC
  • 2
  • 1 comments

アジア太平洋地域の企業、SAPの近代化を加速

Market reaction Comment Full text

INFORMATION SERVICES GROUP INC. (III)

  • Business News
  • May 01, 2026, 16:33 UTC
  • 4
  • 1 comments

亞太地區企業加快推進SAP現代化轉型

Market reaction Comment Full text

KALVISTA PHARMACEUTICALS, INC. (KALV)

  • Business News
  • May 01, 2026, 16:30 UTC
  • 4
  • 1 comments

KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV

Market reaction Comment Full text

PAYCHEX INC (PAYX)

  • Business News
  • May 01, 2026, 16:30 UTC
  • 4
  • 1 comments

Paychex Declares a 10% Increase to Quarterly Cash Dividend

Market reaction Comment Full text

EXP WORLD HOLDINGS, INC. (EXPI)

  • Business News
  • May 01, 2026, 16:20 UTC
  • 3
  • 1 comments

UPDATE – eXp World Holdings to Announce First Quarter 2026 Results on May 11, 2026

Market reaction Comment Full text

Rezolute Inc. (RZLT)

  • Business News
  • May 01, 2026, 16:15 UTC
  • 3
  • 1 comments

Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting

Market reaction Comment Full text
  • Previous
  • 190
  • 191
  • 192
  • 193
  • 194
  • Next

Search

News categories

  • Technical Exchange News(12263)
  • Event(6229)
  • SEC News(267570)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155696)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin